Variant report
Variant | nsv2674 |
---|---|
Chromosome Location | chr2:35800855-35845742 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572358010 | chr2:35800875-35800876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546229337 | chr2:35800934-35800935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376712973 | chr2:35800949-35800950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558225798 | chr2:35800980-35800981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374548296 | chr2:35801028-35801029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182245165 | chr2:35801031-35801032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543085864 | chr2:35801041-35801042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11684649 | chr2:35801045-35801046 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs562295034 | chr2:35801071-35801072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142491061 | chr2:35801107-35801108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76579732 | chr2:35801109-35801110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2372008 | chr2:35801114-35801115 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs144873616 | chr2:35801118-35801119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551751773 | chr2:35801127-35801128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568665745 | chr2:35801129-35801130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373968614 | chr2:35801135-35801136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531288415 | chr2:35801163-35801164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115639396 | chr2:35801170-35801171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185216880 | chr2:35801191-35801192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111313352 | chr2:35801197-35801198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547629875 | chr2:35801217-35801218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6737476 | chr2:35801218-35801219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs11384971 | chr2:35801222-35801223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs397972370 | chr2:35801236-35801237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200382830 | chr2:35801237-35801238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539792879 | chr2:35801254-35801255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148859812 | chr2:35801268-35801269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576543665 | chr2:35801272-35801273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190815397 | chr2:35801322-35801323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555580785 | chr2:35801327-35801328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2719114 | chr2:35801347-35801348 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs554546675 | chr2:35801356-35801357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs577306399 | chr2:35801357-35801358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201218394 | chr2:35801364-35801365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs142241182 | chr2:35801365-35801366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541254092 | chr2:35801390-35801391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs117549792 | chr2:35801426-35801427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2007672 | chr2:35801430-35801431 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs184092873 | chr2:35801442-35801443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563703502 | chr2:35801445-35801446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531229351 | chr2:35801500-35801501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549803514 | chr2:35801529-35801530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188629246 | chr2:35801533-35801534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529025929 | chr2:35801604-35801605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533225898 | chr2:35801611-35801612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547274248 | chr2:35801682-35801683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192924554 | chr2:35801747-35801748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs934970 | chr2:35801817-35801818 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs558735944 | chr2:35801833-35801834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551716643 | chr2:35801905-35801906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:35800800-35803200 | Weak transcription | Pancreas | Pancrea |
2 | chr2:35802800-35803600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:35803200-35803400 | Enhancers | Pancreas | Pancrea |
4 | chr2:35803200-35803800 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
5 | chr2:35808000-35813400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr2:35820000-35821600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr2:35823200-35826000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr2:35823400-35825200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr2:35823400-35825200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr2:35823400-35825200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr2:35825000-35825200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr2:35826800-35827800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr2:35827800-35833400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr2:35833400-35834200 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr2:35834200-35851800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |